Aksamala Adi Andana is primarily engaged in medicinals and botanicals activity. Its headquarters is located in D.I. Yogyakarta. The company was founded in 2016. Aksamala Adi Andana was founded by a group of passionate entrepreneurs dedicated to promoting health and wellness through natural products. The company focuses on the cultivation, processing, and distribution of high-quality medicinal plants and botanical extracts. Their primary business line is the production of herbal medicines, while they also engage in the secondary activity of developing wellness products. The company operates several branches across Indonesia, with a strong presence in Java and Sumatra. Aksamala Adi Andana's main product types include herbal supplements, essential oils, and natural skincare products. Some of their popular brands are "HerbaNusantara" for supplements and "NaturaEssence" for skincare. Internationally, Aksamala Adi Andana exports its products to several countries in Southeast Asia and has plans to expand its footprint to Europe and North America. The company collaborates with local farmers and international research institutions to ensure sustainable sourcing and innovative product development. Aksamala Adi Andana is a member of the Indonesian Herbal Medicine Association and actively participates in industry events to promote the benefits of traditional medicine. The company is committed to sustainability and ethical business practices, aiming to improve community health and well-being. Their vision is to become a leading global provider of natural health solutions, while their mission focuses on harnessing the power of nature to enhance the quality of life for their customers.
Headquarters
RT 3 Dukuh Petung
Bantul; Yogyakarta;
Postal Code: 55184
Contact Details: Purchase the Pt Aksamala Adi Andana report to view the information.
Website: http://www.habbie.co.id, www.protabumin.co.id, www.aksamala.co.id
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service